mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |